🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Relative 5:2 Fasting

Found 0 matching trials

Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

PHASE1

This is an open-label, single-centre, randomized, single dose, three-way cr...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-03-24

Trial ID

NCT02075619

Treatments Being Tested

Amlodipine+Rosuvastatin GSK3074477 FDC - 1 GSK3074477 FDC - 2

A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

PHASE1

The purpose of this study is to estimate the relative bioavailability of TA...

Status

Completed

Location

Radboud University Medical Center, Department of Medical Oncology

Start Date

2019-03-28

Trial ID

NCT03708211

Treatments Being Tested

TAK-931 PIC TAK-931 Tablet Esomeprazole

Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

PHASE1

The purpose of this study is to evaluate the safety, tolerability, and phar...

Status

Completed

Location

Parexel Early Phase Clinic Unit- Los Angeles

Start Date

2016-05-09

Trial ID

NCT02748694

Treatments Being Tested

TAK-041 TAK-041 Placebo

A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses

PHASE1

GSK2982772 is a first-in-class, highly selective, receptor-interacting prot...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-09-27

Trial ID

NCT03266172

Treatments Being Tested

GSK2982772 Modified Release GSK2982772 Immediate Release

Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level

There is a high prevalence of poor sleep quality among university students ...

Status

Completed

Location

Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istinye University

Start Date

2018-09-03

Trial ID

NCT03813420

Treatments Being Tested

Pittsburgh Sleep Quality Index (PSQI)International Physical Activity Questionnaire (IPAQ)The Short Form 36 Health Survey (SF-36)

Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma

PHASE1

This is an open-label, multicenter, sequential, 5-arm, phase 1 study of ora...

Status

Completed

Location

Multiple Locations

Start Date

2011-11-10

Trial ID

NCT01454076

Treatments Being Tested

Ixazomib 2.5 mg Ixazomib 4 mg Capsule A Ixazomib 4 mg Capsule B Ketoconazole Rifampin Clarithromycin Ixazomib 4 mg Capsule B

Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants

PHASE1

The primary purpose of the study is to estimate the relative bioavailabilit...

Status

Completed

Location

Pfizer New Haven Clinical Research Unit

Start Date

2019-06-12

Trial ID

NCT03978143

Treatments Being Tested

Treatment A Treatment B Treatment C Treatment D Treatment E Treatment F Treatment G Treatment H

A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

PHASE1

This study is a randomized, open-label, 5-period, 5-treatment, single-dose,...

Status

Completed

Location

Research Site

Start Date

2016-12-20

Trial ID

NCT02963116

Treatments Being Tested

AZD5718 IR tablet AZD5718 oral suspension Rosuvastatin tablet

Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions

PHASE1

The purpose of this study is to compare the relative bioavailability study ...

Status

Completed

Location

BA Research India Limited

Start Date

2008-01

Trial ID

NCT01131988

Treatments Being Tested

Tacrolimus Capsules

Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults

PHASE1

This project is aimed at understanding whether a new fast-dissolving cheek-...

Status

Recruiting

Location

University of Saskatchewan

Start Date

2024-10-26

Trial ID

NCT06574100

Treatments Being Tested

Cannabidiol Cannabidiol

Previous Next